Skip to main content
OpenTrials

Clinical trial condition

BRCA2 Mutation

Explore clinical trials studying BRCA2 Mutation. Study availability and eligibility vary by location and protocol.

41 public trials 15 recruiting studies
Refine in advanced search Browse all conditions

BRCA2 Mutation trial results

Active, Not Recruiting

Study of Neoadjuvant PARP Inhibition Followed by Radical Prostatectomy in Patients With Unfavorable Intermediate-Risk or High-Risk Prostate Cancer With Select HRR Gene Alterations

NCT05498272

Conditions
BRCA1 Mutation, BRCA2 Mutation, Genital Diseases, +12 more
Locations
  • University of California San Diego - Moores Cancer Center La Jolla, California, United States
  • Johns Hopkins Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States
  • Columbia University Irving Medical Center New York, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details
Active, Not Recruiting

FaCT Trial (Facilitated Cascade Testing Trial)

NCT04613440

Conditions
BRCA1 Mutation, BRCA2 Mutation, Fanconi Anemia, Complementation Group D1
Locations
  • Weill Cornell Medicine New York, United States
  • Duke University Durham, North Carolina, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Active, Not Recruiting

BRCA Founder OutReach (BFOR) Study

NCT03351803

Conditions
BRCA1 Mutation, BRCA2 Mutation
Locations
  • University of California, Los Angeles Los Angeles, California, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Memorial Sloan - Kettering Cancer Center New York, United States
View Trial Details

Related conditions